Skip to main content

Neoliberalising Bioethics: Bias, Enhancement and Economistic Ethics

Abstract

In bioethics there is an ongoing debate about the ethical case for human enhancement through new biomedical technologies. In this debate there are both supporters and opponents of human enhancement technologies such as genetic improvements of cognitive abilities (eg, intelligence). The supporters argue that human enhancement will lead to healthier and therefore better lives, meaning that any delays to the introduction of such technologies is problematic. In contrast, the opponents argue that new technologies will not solve problems such as inequality and social justice. In order to overcome opposition to human enhancement, Bostrom and Ord have outlined a test to evaluate ethical arguments for "status quo bias" or what they call "intuitive judgements" in the assessment of human enhancement. This article is a response to their paper in which I raise a number of problems with their position, particularly with their "status quo bias" test and the incorporation of economistic thinking into their ethical arguments.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kean Birch.

Rights and permissions

Open Access This is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License ( https://creativecommons.org/licenses/by-nc/2.0 ), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

Reprints and Permissions

About this article

Cite this article

Birch, K. Neoliberalising Bioethics: Bias, Enhancement and Economistic Ethics. Life Sci Soc Policy 4, 1 (2008). https://doi.org/10.1186/1746-5354-4-2-1

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/1746-5354-4-2-1

Keywords

  • Ethical Argument
  • Human Enhancement
  • Genetic Enhancement
  • Enhancement Technology
  • ESRC Genomic Network